Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polio”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03239496
What this trial is testing

Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

Who this might be right for
Poliomyelitis
Fidec Corporation 773
Large-scale testing (Phase 3)WithdrawnNCT03128489
What this trial is testing

Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants

Who this might be right for
DiphtheriaAcellular PertussisHaemophilus Influenzae Type b+2 more
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT05163561
What this trial is testing

Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine

Who this might be right for
Poliomyelitis
Serum Institute of India Pvt. Ltd. 1,072
Large-scale testing (Phase 3)Study completedNCT01389687
What this trial is testing

Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan

Who this might be right for
PoliomyelitisPolio
Sanofi Pasteur, a Sanofi Company 74
Large-scale testing (Phase 3)Study completedNCT01813604
What this trial is testing

Immunogenicity of Inactivated and Live Polio Vaccines

Who this might be right for
Poliomyelitis
Centers for Disease Control and Prevention 1,206
Post-approval studies (Phase 4)UnknownNCT01841671
What this trial is testing

Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine

Who this might be right for
Polio
University of Chile 570
Post-approval studies (Phase 4)Study completedNCT03546634
What this trial is testing

Sero-conversion Study for a Two-dose Schedule of Sabin IPV in China

Who this might be right for
Poliomyelitis
Centers for Disease Control and Prevention, China 280
Large-scale testing (Phase 3)Ended earlyNCT02176863
What this trial is testing

Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome

Who this might be right for
Post-polio Syndrome
Instituto Grifols, S.A. 191
Early research (Phase 1)Not Yet RecruitingNCT07688369
What this trial is testing

Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults

Who this might be right for
Polio Immunity
Serum Institute of India Pvt. Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT02347423
What this trial is testing

3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants

Who this might be right for
Poliomyelitis
Statens Serum Institut 824
Large-scale testing (Phase 3)Study completedNCT00879827
What this trial is testing

Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants

Who this might be right for
DiphtheriaPoliomyelitisHepatitis B+2 more
GlaxoSmithKline 60
Large-scale testing (Phase 3)Study completedNCT02458183
What this trial is testing

Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Boryung Pharmaceutical Co., Ltd 476
Post-approval studies (Phase 4)Study completedNCT02189811
What this trial is testing

Polio End-game Strategies - Poliovirus Type 2 Challenge Study

Who this might be right for
Poliomyelitis
Aga Khan University 900
Not applicableStudy completedNCT01229579
What this trial is testing

Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan

Who this might be right for
Poliomyelitis
Aga Khan University 320
Post-approval studies (Phase 4)Study completedNCT03147560
What this trial is testing

Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants

Who this might be right for
Polio
Zhejiang Provincial Center for Disease Control and Prevention 528
Testing effectiveness (Phase 2)Study completedNCT00970307
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 421
Early research (Phase 1)Study completedNCT01997632
What this trial is testing

Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults

Who this might be right for
Poliomyelitis
University Hospital, Ghent 120
Testing effectiveness (Phase 2)Looking for participantsNCT06137664
What this trial is testing

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

Who this might be right for
Poliomyelitis
PATH 2,400
Large-scale testing (Phase 3)Study completedNCT00287092
What this trial is testing

Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

Who this might be right for
PertussisDiphtheriaTetanus+2 more
Sanofi Pasteur, a Sanofi Company 807
Testing effectiveness (Phase 2)Study completedNCT04693286
What this trial is testing

Clinical Trial of Novel OPV2 Vaccine

Who this might be right for
Poliomyelitis
International Centre for Diarrhoeal Disease Research, Bangladesh 330
Next Page